Maintenance of weight loss or stability in subjects with obesity: a retrospective longitudinal analysis of a real-world population

被引:18
|
作者
DerSarkissian, Maral [1 ]
Bhak, Rachel H. [1 ]
Huang, Joanna [2 ]
Buchs, Sarah [2 ]
Vekeman, Francis [1 ]
Smolarz, B. Gabriel [2 ]
Brett, Jason [2 ]
Ganguly, Rahul [2 ]
Duh, Mei Sheng [1 ]
机构
[1] Anal Grp Inc, Boston, MA USA
[2] Novo Nordisk Inc, Plainsboro, NJ USA
关键词
BMI; Obesity; Weight loss; Weight maintenance; LONG-TERM; PREVALENCE;
D O I
10.1080/03007995.2017.1307173
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Characterize patterns of weight change among subjects with obesity. Methods: A retrospective observational longitudinal study of subjects with obesity was conducted using the General Electric Centricity electronic medical record database. Subjects who were >= 18 years old with BMI >= 30 kg/m(2) (first defining index BMI), had no medical conditions associated with unintentional weight loss, and had >= 4 BMI measurements/year for >= 2.5 years were included and categorized into groups (stable weight: within <5% of index BMI; modest weight loss: >= 5 to <10% of index BMI lost; moderate weight loss: >= 10 to <15%of index BMI lost; and high weight loss: >= 15% of index BMI lost) based on weight change during 6 months following index. No interventions were considered. Patterns of weight change were then assessed for 2 years. Results: A total of 177,743 subjects were included: 85.1% of subjects were in the stable weight, 9.3% in the modest, 2.3% in the moderate, and 3.3% in the high weight loss groups. The proportion of subjects who maintained or continued to lose weight decreased over the 2 year observation period; 11% of those with high weight loss continued to lose weight and 19% maintained their weight loss. This group had the lowest percentage of subjects who regained >= 50% of lost weight and the lowest proportion of subjects with weight cycling (defined as not continuously losing, gaining, or maintaining weight throughout the 2 year observation period relative to its beginning). This trend persisted in subgroups with class II-III obesity, pre-diabetes, and type 2 diabetes. Conclusion: Weight cycling and regain were commonly observed. Subjects losing the most weight during the initial period were more likely to continue losing weight.
引用
收藏
页码:1105 / 1110
页数:6
相关论文
共 50 条
  • [31] A Longitudinal Analysis of Real-World Self-report Data
    van Berkel, Niels
    Shalawadi, Sujay
    Evans, Madeleine R.
    Visuri, Aku
    Hosio, Simo
    HUMAN-COMPUTER INTERACTION - INTERACT 2023, PT III, 2023, 14144 : 611 - 632
  • [32] Unmet weight loss targets in real-world clinical practice: weight management and perceptions in China
    Lin, Ziwei
    Si, Si
    Liu, Jia
    Zhu, Hao
    Xu, Jiawei
    Artime, Esther
    Khare, Swarna
    Higgins, Victoria
    Leith, Andrea
    Qu, Shen
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [33] Weight Loss Medication Prescribing Patterns: Real-World Data Analysis from 2015-2023
    Albogami, Yasser
    Aldemikhi, Reem
    Bashrahel, Raghad
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 585 - 585
  • [34] Predictors of Engagement and Weight Loss in Real-World Diabetes Prevention Program (DPP)
    Auyoung, Mona
    Luu, Kimberly
    Ruiz, Monica
    Walker, Chris
    Philis-Tsimikas, Athena
    Fortmann, Addie L.
    DIABETES, 2019, 68
  • [35] The Challenge of Defining the Optimal Lifestyle Weight Loss Intervention for Real-world Settings
    Wing, Rena R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (22): : 2213 - 2214
  • [36] Use of liraglutide and dulaglutide for weight loss: real-world observations on efficacy and tolerability
    Ludgate, S.
    Kennedy, C.
    Ho, K.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 : S234 - S235
  • [37] Efficacy and safety of intragastric balloon therapy compared to a multidisciplinary weight loss program (OPTIFAST) in a real-world population - a propensity score matching analysis
    Oster, Miriam
    Hein, Nathalena
    Aksan, Ayseguel
    Krammer, Heiner
    Theodoridou, Sophia
    Stein, Juergen
    OBESITY FACTS, 2023, 16 (01) : 89 - 98
  • [38] Effects of Two Weight-Loss Medications, Liraglutide and Orlistat, on Liver Enzymes in Patients with Overweight or Obesity in a Real-World Setting
    Gorgojo-Martinez, Juan J.
    Chicharro, Pablo L. Lois
    Ferreira-Ocampo, Pablo J.
    Doejo-Marciales, Sandra C.
    Barra-Malig, Solange F.
    Almodovar-Ruiz, Francisca
    DIABETES, 2022, 71
  • [39] Modification of systemic anti-cancer therapies and weight loss, a population-level real-world evidence study
    Shaw, Clare
    Starling, Naureen
    Reich, Adam
    Wilkes, Emily
    White, Rebecca
    Shepelev, Julian
    Narduzzi, Silvia
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [40] Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian Population
    Ahmadzada, Tamkin
    Cooper, Wendy A.
    Holmes, Mikaela
    Mahar, Annabelle
    Westman, Helen
    Gill, Anthony J.
    Nordman, Ina
    Yip, Po Yee
    Pal, Abhijit
    Zielinski, Rob
    Pavlakis, Nick
    Nagrial, Adnan
    Daneshvar, Dariush
    Brungs, Daniel
    Karikios, Deme
    Aleksova, Vesna
    Grau, Georges E.
    Burn, Juliet
    Asher, Rebecca
    Hosseini-Beheshti, Elham
    Reid, Glen
    Clarke, Stephen
    Kao, Steven
    Asher, Rebecca
    JTO CLINICAL AND RESEARCH REPORTS, 2020, 1 (04): : 1 - 15